115 related articles for article (PubMed ID: 12402286)
1. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
Langenbach KJ; Rando TA
Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
[TBL] [Abstract][Full Text] [Related]
2. Laminin polymerization induces a receptor-cytoskeleton network.
Colognato H; Winkelmann DA; Yurchenco PD
J Cell Biol; 1999 May; 145(3):619-31. PubMed ID: 10225961
[TBL] [Abstract][Full Text] [Related]
3. The Role of β-Dystroglycan in Nuclear Dynamics.
Cook M; Stevenson B; Jacobs LA; Leocadio Victoria D; Cisneros B; Hobbs JK; Stewart CL; Winder SJ
Cells; 2024 Feb; 13(5):. PubMed ID: 38474395
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: From adhesion complex to signaling hub: the dual role of dystroglycan.
Sciandra F; Bozzi M; Bigotti MG
Front Mol Biosci; 2024; 11():1388846. PubMed ID: 38562555
[TBL] [Abstract][Full Text] [Related]
5. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.
Ervasti JM; Campbell KP
J Cell Biol; 1993 Aug; 122(4):809-23. PubMed ID: 8349731
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of human protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1, POMGnT1.
Akasaka-Manya K; Manya H; Kobayashi K; Toda T; Endo T
Biochem Biophys Res Commun; 2004 Jul; 320(1):39-44. PubMed ID: 15207699
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum.
Matejas V; Hinkes B; Alkandari F; Al-Gazali L; Annexstad E; Aytac MB; Barrow M; Bláhová K; Bockenhauer D; Cheong HI; Maruniak-Chudek I; Cochat P; Dötsch J; Gajjar P; Hennekam RC; Janssen F; Kagan M; Kariminejad A; Kemper MJ; Koenig J; Kogan J; Kroes HY; Kuwertz-Bröking E; Lewanda AF; Medeira A; Muscheites J; Niaudet P; Pierson M; Saggar A; Seaver L; Suri M; Tsygin A; Wühl E; Zurowska A; Uebe S; Hildebrandt F; Antignac C; Zenker M
Hum Mutat; 2010 Sep; 31(9):992-1002. PubMed ID: 20556798
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
Jayasinha V; Nguyen HH; Xia B; Kammesheidt A; Hoyte K; Martin PT
Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
[TBL] [Abstract][Full Text] [Related]
9. The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy.
Swiderski K; Chan AS; Herold MJ; Kueh AJ; Chung JD; Hardee JP; Trieu J; Chee A; Naim T; Gregorevic P; Lynch GS
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38602028
[TBL] [Abstract][Full Text] [Related]
10. From adhesion complex to signaling hub: the dual role of dystroglycan.
Sciandra F; Bozzi M; Bigotti MG
Front Mol Biosci; 2023; 10():1325284. PubMed ID: 38155958
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies.
Rawls A; Diviak BK; Smith CI; Severson GW; Acosta SA; Wilson-Rawls J
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892218
[TBL] [Abstract][Full Text] [Related]
12. Dual transgene amelioration of Lama2-null muscular dystrophy.
McKee KK; Yurchenco PD
Matrix Biol; 2023 Apr; 118():1-15. PubMed ID: 36878377
[TBL] [Abstract][Full Text] [Related]
13. AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG).
Balakrishnan B; Altassan R; Budhraja R; Liou W; Lupo A; Bryant S; Mankouski A; Radenkovic S; Preston GJ; Pandey A; Boudina S; Kozicz T; Morava E; Lai K
Transl Res; 2023 Jul; 257():1-14. PubMed ID: 36709920
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology.
Bencze M
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613804
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the extracellular matrix and integrin signalling proteins in skeletal muscle glucose uptake.
Draicchio F; Behrends V; Tillin NA; Hurren NM; Sylow L; Mackenzie R
J Physiol; 2022 Oct; 600(20):4393-4408. PubMed ID: 36054466
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms and Risk Factors for the Pathogenesis of Hydrocephalus.
Li J; Zhang X; Guo J; Yu C; Yang J
Front Genet; 2021; 12():777926. PubMed ID: 35047005
[TBL] [Abstract][Full Text] [Related]
17. Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies.
Ortiz-Cordero C; Bincoletto C; Dhoke NR; Selvaraj S; Magli A; Zhou H; Kim DH; Bang AG; Perlingeiro RCR
Stem Cell Reports; 2021 Nov; 16(11):2752-2767. PubMed ID: 34653404
[TBL] [Abstract][Full Text] [Related]
18. Shared and distinct mechanisms of skeletal muscle atrophy: A narrative review.
Wilburn D; Ismaeel A; Machek S; Fletcher E; Koutakis P
Ageing Res Rev; 2021 Nov; 71():101463. PubMed ID: 34534682
[TBL] [Abstract][Full Text] [Related]
19. The Laminin-Induced Phosphorylation of PKCδ Regulates AQP4 Distribution and Water Permeability in Rat Astrocytes.
Noël G; Tham DKL; Guadagno E; MacVicar B; Moukhles H
Cell Mol Neurobiol; 2021 Nov; 41(8):1743-1757. PubMed ID: 32851539
[TBL] [Abstract][Full Text] [Related]
20. A signaling hub of insulin receptor, dystrophin glycoprotein complex and plakoglobin regulates muscle size.
Eid Mutlak Y; Aweida D; Volodin A; Ayalon B; Dahan N; Parnis A; Cohen S
Nat Commun; 2020 Mar; 11(1):1381. PubMed ID: 32170063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
